Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death

BACKGROUND: Limited data are available on the effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines in real-world use—especially against Omicron variants in SARS-CoV-2 infection-naïve population. METHODS: A matched case-control study was conducted among people aged ≥ 3 years between 2 December...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Zhuoying, Xu, Shuangfei, Liu, Jiechen, Wu, Linlin, Qiu, Jing, Wang, Nan, Ren, Jia, Li, Zhi, Guo, Xiang, Tao, Fangfang, Chen, Jian, Lu, Donglei, Sun, Xiaodong, Wang, Weibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583051/
https://www.ncbi.nlm.nih.gov/pubmed/36266697
http://dx.doi.org/10.1186/s12916-022-02606-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583051/
https://www.ncbi.nlm.nih.gov/pubmed/36266697
http://dx.doi.org/10.1186/s12916-022-02606-8

Ejemplares similares